Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LINDE PLCLIN · Entity 2835 | Executive VP, APAC | September 10, 2024 | September 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LINDE PLC
Report date September 10, 2024 · Filed September 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 17,583.8924 |
Reported balance
After 2024-09-10 transaction · row 1
1 source rowRow 1 · 2024-09-10 · Sale · Disposed 10,025 · Balance 17,583.8924 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,390 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 1,390 F1: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,550 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 1,550 F2: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,430 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 1,430 F3: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07 | Direct | 9,010 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 9,010 F4: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07 | Direct | 10,245 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 10,245 F5: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07 | Direct | 12,395 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 12,395 F6: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08 | Direct | 19,070 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 19,070 F7: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09 | Direct | 10,175 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 10,175 F8: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20 | Direct | 3,899 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 3,899 F9: This option vests over three years in three consecutive equal annual installments beginning on March 20,2020. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 219.06 |
Reported balance
Holding disclosure · report date 2024-09-10 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 219.06 F10: Conversion to Linde plc Ordinary Shares is on a one-to-one basis. F11: Deferred stock units acquired under the Linde Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
F2: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
F3: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
F4: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
F5: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
F6: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
F7: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
F8: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F9: This option vests over three years in three consecutive equal annual installments beginning on March 20,2020.
F10: Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
F11: Deferred stock units acquired under the Linde Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Mar 9, 2021 17:15 UTC | LINDE PLC LIN · Entity 2835 | GrantRestricted Stock Units · Derivative | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002519 · form4.xml · derivative · entry 3 Panikar John · CIK 0001504943 · Executive VP, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,810 Underlying: Ordinary Shares · 1,810 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:15 UTC | LINDE PLC LIN · Entity 2835 | GrantDeferred Stock Units · Derivative | 24.889 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002519 · form4.xml · derivative · entry 10 Panikar John · CIK 0001504943 · Executive VP, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94.951 Underlying: Ordinary Shares · 94.951 shares Expires not disclosed F8 · derivative.exercise_price: Conversion to Linde plc Ordinary Shares is on a one-to-one basis. F9 · derivative.exercise_date: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. F9 · derivative.expiration_date: Deferred stock units acquired under the Compensation Deferred Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:27 UTC | LINDE PLC LIN · Entity 2835 | Exercise / conversionRestricted Stock Units · Derivative | 3,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002289 · form4.xml · derivative · entry 4 Panikar John · CIK 0001504943 · Executive VP, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,030 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 27, 2018. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 27, 2018. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 27, 2018. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:27 UTC | LINDE PLC LIN · Entity 2835 | Tax withholdingOrdinary Shares | 1,193 | $244.27 | $291,414.11 |
DisclosureSEC source: 0001062993-21-002289 · form4.xml · nonDerivative · entry 2 Panikar John · CIK 0001504943 · Executive VP, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,100.9108 F2 · shares: Ordinary shares withheld from the RSU payout to cover tax withholdings. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:27 UTC | LINDE PLC LIN · Entity 2835 | Exercise / conversionOrdinary Shares | 3,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002289 · form4.xml · nonDerivative · entry 1 Panikar John · CIK 0001504943 · Executive VP, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,293.9108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 27, 2018. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 27, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.